Terumo
Europe NV Press
Releases
November 9, 2009:
Terumo Introduces the World’s First Oxygenators with a Truly Integrated Arterial Filter
July 24, 2009:
Terumo Europe announces the initiation of e-MISAGO Registry and Misago® stent range expansion
May 19, 2009:
Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart™ Left Ventricular Assist System
March 23, 2009:
Terumo completes enrolment of 3000 patients in NOBORI 2 – a Nobori® Drug Eluting Stent Trial
June 6, 2008:
World
Wide Development and Distribution agreement for an Automated Whole Blood
or Blood Component Processing system.
April 28, 2008:
Japanese
Global Medical Technology Company Opens Office in Switzerland.
February 15, 2008:
Terumo
Announces First CE Certified NOBORI™ DES in Use.
January 18, 2008:
Terumo
receives CE Certificate for NOBORI™ DRUG-ELUTING STENT.
October 23, 2007:
Terumo’s
NOBORI™ Drug Eluting Stent System continues to show exellent results.
October 27, 2006:
Terumo
Europe N.V. (Belgium) opens Representative Office in Moscow.
April 27, 2006:
Terumo
and Biocompatibles establish European marketing partnership for Drug Eluting
Bead products.
February 28, 2006:
Terumo Announces Acquisition of MicroVention.
May 26, 2005:
Terumo
Europe N.V. enrols First Patient in Clinical Trial of the Nobori™ Drug-eluting
Coronary Stent.
March
31, 2005:
Introduction of DC BEAD™ on Key European Markets.
December
17, 2004:
Terumo Announces Initiation of NOBORI 1 Clinical Trial.
December
15, 2004:
Terumo Initiates Vulnerable Plaque Program with Exclusive
License from Massachusetts General Hospital.
January 19, 2004:
Terumo
Heart, Inc. Announces the World's First Implant of the DuraHeart LVAS.
October
28, 2003:
Biosensors and Terumo Sign Licensing Agreement on
First Drug-Eluting Stent to Undergo Full Clinical Trials in Japan.
October 23, 2003:
Global Distribution Agreement with
TERUMO for Bead Block™ is announced
by Biocompatibles International PLC.
|